Oliver Politz

2.9k total citations
53 papers, 2.4k citations indexed

About

Oliver Politz is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Oliver Politz has authored 53 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 13 papers in Immunology. Recurrent topics in Oliver Politz's work include PI3K/AKT/mTOR signaling in cancer (9 papers), Biofuel production and bioconversion (7 papers) and Enzyme Production and Characterization (7 papers). Oliver Politz is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (9 papers), Biofuel production and bioconversion (7 papers) and Enzyme Production and Characterization (7 papers). Oliver Politz collaborates with scholars based in Germany, United States and Denmark. Oliver Politz's co-authors include Sergij Goerdt, Vitam Kodelja, Kai Schledzewski, Pierre Guillot, Alexei Gratchev, C. Müller, Rainer Borriss, Nahid Hakiy, Bernard Haendler and C.E. Orfanos and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Oliver Politz

52 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oliver Politz Germany 20 1.0k 801 456 305 256 53 2.4k
Kuang‐Hui Sun Taiwan 30 948 0.9× 946 1.2× 444 1.0× 182 0.6× 120 0.5× 83 2.2k
Mitsugu Fujita Japan 29 1.2k 1.1× 1.3k 1.6× 1000 2.2× 226 0.7× 462 1.8× 114 3.2k
Giusy Di Conza Italy 19 1.3k 1.2× 1.4k 1.7× 711 1.6× 181 0.6× 141 0.6× 37 2.8k
Gábor Járai United Kingdom 32 1.1k 1.1× 525 0.7× 347 0.8× 968 3.2× 114 0.4× 63 2.8k
Shuo Ma United States 28 1.2k 1.2× 733 0.9× 762 1.7× 213 0.7× 72 0.3× 160 3.2k
Ko‐Jiunn Liu Taiwan 26 1.0k 1.0× 549 0.7× 473 1.0× 245 0.8× 69 0.3× 65 2.4k
Daniel L. Worthley Australia 24 935 0.9× 419 0.5× 936 2.1× 314 1.0× 93 0.4× 64 2.3k
Masuo Hosokawa Japan 30 1.2k 1.1× 779 1.0× 854 1.9× 202 0.7× 180 0.7× 88 2.7k
Curtis B. Thompson United States 24 1.3k 1.3× 430 0.5× 1.1k 2.5× 234 0.8× 124 0.5× 51 2.6k
Flavio Salazar‐Onfray Chile 34 1.1k 1.1× 2.1k 2.6× 1.1k 2.5× 136 0.4× 106 0.4× 83 3.3k

Countries citing papers authored by Oliver Politz

Since Specialization
Citations

This map shows the geographic impact of Oliver Politz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Politz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Politz more than expected).

Fields of papers citing papers by Oliver Politz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Politz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Politz. The network helps show where Oliver Politz may publish in the future.

Co-authorship network of co-authors of Oliver Politz

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Politz. A scholar is included among the top collaborators of Oliver Politz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Politz. Oliver Politz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sugawara, Tatsuo, Ekaterina Nevedomskaya, Simon Heller, et al.. (2024). Dual targeting of the androgen receptor and PI3K / AKT / mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis. Molecular Oncology. 18(3). 726–742. 13 indexed citations
2.
3.
Sartori, Giulio, Chiara Tarantelli, Filippo Spriano, et al.. (2023). The ATR inhibitor elimusertib exhibits anti‐lymphoma activity and synergizes with the PI3K inhibitor copanlisib. British Journal of Haematology. 204(1). 191–205. 7 indexed citations
4.
O’Donovan, Daniel H., et al.. (2023). Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment. International Journal of Molecular Sciences. 24(3). 2289–2289. 32 indexed citations
5.
Heller, Simon, Andreas Janzer, Helge G. Roider, et al.. (2023). Pan-PI3K inhibition with copanlisib overcomes Treg- and M2-TAM-mediated immune suppression and promotes anti-tumor immune responses. Clinical and Experimental Medicine. 23(8). 5445–5461. 7 indexed citations
6.
Zitzmann-Kolbe, Sabine, Alexander Kristian, Dieter Zopf, et al.. (2023). A Targeted Thorium-227 Conjugate Demonstrates Efficacy in Preclinical Models of Acquired Drug Resistance and Combination Potential with Chemotherapeutics and Antiangiogenic Therapies. Molecular Cancer Therapeutics. 22(9). 1073–1086. 3 indexed citations
7.
Serna, Garazi, Claudia Valverde, Joan Carles, et al.. (2020). Preclinical Activity of PI3K Inhibitor Copanlisib in Gastrointestinal Stromal Tumor. Molecular Cancer Therapeutics. 19(6). 1289–1297. 11 indexed citations
8.
Huang, Dachuan, Tammy Song, Maarja‐Liisa Nairismägi, et al.. (2020). Evaluation of the PIK3 pathway in peripheral T‐cell lymphoma and NK/T‐cell lymphoma. British Journal of Haematology. 189(4). 731–744. 20 indexed citations
9.
10.
Rudolph, Marion, Tobias Anzeneder, Georg Beckmann, et al.. (2016). AKT1 E17K mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detection. BMC Cancer. 16(1). 622–622. 66 indexed citations
11.
Politz, Oliver, et al.. (2004). Androgen receptor function is modulated by the tissue-specific AR45 variant. FEBS Journal. 272(1). 74–84. 56 indexed citations
12.
Politz, Oliver, et al.. (2004). Androgen receptor function is modulated by the tissue‐specific AR45 variant. FEBS Journal. 272(1). 74–84. 90 indexed citations
13.
Politz, Oliver, Alexei Gratchev, Peter McCourt, et al.. (2002). Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochemical Journal. 362(1). 155–155. 247 indexed citations
14.
Gratchev, Alexei, Pierre Guillot, Nahid Hakiy, et al.. (2001). Alternatively Activated Macrophages Differentially Express Fibronectin and Its Splice Variants and the Extracellular Matrix Protein βIG‐H3. Scandinavian Journal of Immunology. 53(4). 386–392. 231 indexed citations
15.
Politz, Oliver, et al.. (2000). A highly thermostable endo-(1,4)-β-mannanase from the marine bacterium Rhodothermus marinus. Applied Microbiology and Biotechnology. 53(6). 715–721. 59 indexed citations
16.
Kodelja, Vitam, Stefan Kraft, Oliver Politz, et al.. (1998). Langerhans cells do not express alternative macrophage activation-associated CC chemokine (AMAC)-1. Research in Immunology. 149(7-8). 633–637. 8 indexed citations
17.
Welfle, Karin, Oliver Politz, Rainer Borriss, Rolf Misselwitz, & Heinz Welfle. (1996). Individual amino acids in the N‐terminal loop region determine the thermostability and unfolding characteristics of bacterial glucanases. Protein Science. 5(11). 2255–2265. 10 indexed citations
18.
Hahn, Michael G., Ole Olsen, Oliver Politz, Rainer Borriss, & Udo Heinemann. (1995). Crystal Structure and Site-directed Mutagenesis of Bacillus macerans Endo-1,3–1,4-β-glucanase. Journal of Biological Chemistry. 270(7). 3081–3088. 98 indexed citations
19.
Welfle, Karin, Rolf Misselwitz, Heinz Welfle, Oliver Politz, & Rainer Borriss. (1995). Influence of Ca2+ on Conformation and Stability of Three Bacterial Hybrid Glucanases. European Journal of Biochemistry. 229(3). 726–735. 15 indexed citations
20.
Politz, Oliver, Ortwin Simon, Ole Olsen, & Rainer Borriss. (1993). Determinants for the enhanced thermostability of hybrid (1‐3,1‐4)‐β‐glucanases. European Journal of Biochemistry. 216(3). 829–834. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kuang‐Hui Sun Breakdown of academic impact, for papers by Mitsugu Fujita Breakdown of academic impact, for papers by Giusy Di Conza Breakdown of academic impact, for papers by Gábor Járai Breakdown of academic impact, for papers by Shuo Ma Breakdown of academic impact, for papers by Ko‐Jiunn Liu Breakdown of academic impact, for papers by Daniel L. Worthley Breakdown of academic impact, for papers by Masuo Hosokawa Breakdown of academic impact, for papers by Curtis B. Thompson Breakdown of academic impact, for papers by Flavio Salazar‐Onfray
Rankless by CCL
2026